Index S&P 500
P/E -
EPS (ttm) -6.69
Insider Own 17.72%
Shs Outstand 864.46M
Perf Week 0.87%
Market Cap 9.48B
Forward P/E 7.47
EPS next Y 1.47
Insider Trans 0.00%
Shs Float 711.52M
Perf Month -1.75%
Income -5779.00M
PEG -
EPS next Q 0.33
Inst Own 63.19%
Short Float 4.76%
Perf Quarter -3.31%
Sales 151.94B
P/S 0.06
EPS this Y -42.21%
Inst Trans 1.40%
Short Ratio 1.62
Perf Half Y 17.27%
Book/sh 8.22
P/B 1.33
EPS next Y -11.75%
ROA -7.49%
Short Interest 33.89M
Perf Year -38.43%
Cash/sh 1.31
P/C 8.38
EPS next 5Y -15.72%
ROE -56.13%
52W Range 8.08 - 18.83
Perf YTD 17.52%
Dividend Est. 0.83 (7.55% )
P/FCF 16.61
EPS past 5Y -
ROI -16.83%
52W High -41.77%
Beta 0.74
Dividend TTM 0.75 (6.84% )
Quick Ratio 0.32
Sales past 5Y 1.77%
Gross Margin 15.77%
52W Low 35.71%
ATR (14) 0.21
Dividend Ex-Date Nov 18, 2024
Current Ratio 0.61
EPS Y/Y TTM -1104.67%
Oper. Margin 0.27%
RSI (14) 51.46
Volatility 0.91% 1.91%
Employees 312000
Debt/Eq 4.38
Sales Y/Y TTM 5.08%
Profit Margin -3.80%
Recom 2.85
Target Price 11.88
Option/Short Yes / Yes
LT Debt/Eq 3.83
EPS Q/Q 51.80%
Payout -
Rel Volume 0.36
Prev Close 11.01
Sales Surprise 1.63%
EPS Surprise 17.85%
Sales Q/Q 4.15%
Earnings Apr 08 BMO
Avg Volume 20.95M
Price 10.97
SMA20 0.55%
SMA50 0.22%
SMA200 7.89%
Trades
Volume 7,737,403
Change -0.41%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-28-25 Downgrade
Deutsche Bank
Hold → Sell
$11 → $9
Feb-26-24 Initiated
Leerink Partners
Market Perform
$23
Feb-20-24 Downgrade
HSBC Securities
Hold → Reduce
Jan-03-24 Initiated
Barclays
Underweight
$21
Dec-22-23 Initiated
HSBC Securities
Hold
$27
Oct-23-23 Upgrade
JP Morgan
Neutral → Overweight
$27 → $30
Jul-03-23 Reiterated
Morgan Stanley
Underweight
$37 → $27
Jun-28-23 Downgrade
Deutsche Bank
Buy → Hold
$46 → $34
Feb-23-23 Initiated
Loop Capital
Buy
$45
Nov-23-22 Resumed
Morgan Stanley
Underweight
$39
Nov-22-22 Upgrade
Cowen
Market Perform → Outperform
$43 → $54
Nov-18-22 Upgrade
JP Morgan
Neutral → Overweight
$42
Nov-11-22 Upgrade
Deutsche Bank
Hold → Buy
Apr-01-22 Downgrade
Robert W. Baird
Outperform → Neutral
$70 → $51
Dec-16-21 Downgrade
Morgan Stanley
Equal-Weight → Underweight
$56 → $49
Mar-25-21 Reiterated
Deutsche Bank
Hold
$49 → $55
Jan-11-21 Upgrade
Robert W. Baird
Neutral → Outperform
$55
Jan-11-21 Upgrade
Guggenheim
Neutral → Buy
$55
Jan-08-21 Resumed
Credit Suisse
Neutral
$42
Apr-06-20 Upgrade
UBS
Sell → Neutral
$49 → $44
Show Previous Ratings
Apr-28-25 09:50AM
Apr-26-25 03:00PM
12:00AM
(Thomson Reuters StreetEvents)
Apr-25-25 09:00AM
Apr-24-25 10:35AM
02:29PM
Loading…
Apr-23-25 02:29PM
07:29AM
06:30AM
Apr-22-25 06:52PM
03:00PM
01:24PM
12:05PM
08:24AM
05:24AM
12:35AM
04:20PM
Loading…
Apr-21-25 04:20PM
02:20PM
01:33PM
12:13PM
12:09PM
Apr-19-25 07:00AM
Apr-18-25 06:20AM
Apr-17-25 05:08PM
08:44AM
08:10AM
03:10AM
Apr-15-25 03:43PM
10:15AM
Apr-14-25 08:15AM
Apr-13-25 07:38AM
10:00AM
Loading…
Apr-12-25 10:00AM
08:45AM
Apr-11-25 02:46PM
Apr-10-25 04:58PM
11:47AM
11:47AM
Apr-09-25 07:28AM
07:26AM
Apr-08-25 03:32PM
(The Wall Street Journal)
02:08PM
01:45PM
12:04PM
11:18AM
(The Wall Street Journal)
11:17AM
10:57AM
(Associated Press Finance)
10:24AM
10:23AM
10:11AM
10:03AM
09:54AM
09:30AM
09:19AM
09:07AM
08:35AM
(The Wall Street Journal)
08:15AM
07:21AM
07:13AM
(Associated Press Finance)
07:07AM
07:00AM
Apr-07-25 03:00PM
11:20AM
08:50AM
08:38AM
08:00AM
Apr-03-25 09:00AM
05:14AM
Apr-01-25 08:15AM
06:20AM
Mar-31-25 09:35AM
Mar-28-25 05:37AM
Mar-27-25 03:26PM
01:25PM
12:58PM
09:50AM
08:08AM
07:00AM
05:15AM
Mar-26-25 08:50AM
Mar-25-25 04:40AM
Mar-24-25 01:48PM
11:30AM
Mar-23-25 07:21AM
Mar-22-25 03:20AM
Mar-21-25 05:25PM
01:37PM
12:12PM
08:11AM
Mar-20-25 10:00AM
09:40AM
07:45AM
07:38AM
Mar-18-25 05:50PM
09:43AM
08:20AM
01:15AM
Mar-15-25 07:00AM
Mar-12-25 04:23PM
02:26PM
10:53AM
Mar-11-25 05:45PM
Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Walgreens Boots Alliance, Inc. Former 10% owner Feb 18 '25 Sale 21.16 12,000,000 253,920,000 11,239,996 Feb 20 04:30 PM Walgreens Boots Alliance, Inc. 10% Owner Feb 06 '25 Sale 244.51 1,286,376 314,531,796 12,570,000 Feb 10 07:35 PM Walgreens Boots Alliance Holdi Affiliate Feb 06 '25 Proposed Sale 246.13 1,081,885 266,284,355 Feb 06 07:55 PM Walgreens Boots Alliance, Inc. 10% Owner Sep 11 '24 Sale 11.13 11,619,998 129,330,578 23,239,996 Sep 13 07:04 PM Walgreens Boots Alliance, Inc. 10% Owner Aug 01 '24 Sale 240.56 4,438,171 1,067,646,416 19,980,000 Aug 05 06:44 PM Walgreens Boots Alliance Holdi Affiliate Aug 01 '24 Proposed Sale 244.46 3,398,929 830,902,183 Aug 01 08:56 PM Walgreens Boots Alliance, Inc. 10% Owner May 22 '24 Sale 215.12 1,859,390 400,000,158 24,418,171 May 24 04:05 PM